The evidence does not indicate that AstraZeneca’s vaccine caused blood clots in people vaccinated against COVID, the UK regulator, the Medicines and Healthcare Products Regulatory Authority (MHRA), said.
Earlier, several EU countries, including Austria, France, Germany, Italy, the Netherlands, Spain, and others temporarily suspended vaccination with the AstraZeneca drug because of reports of possible thromboembolic complications in those vaccinated. The European Medicines Agency (EMA) said in a statement that it was investigating the incidents and took the position that vaccination with AstraZeneca was possible while the investigation was ongoing.
“After a thorough scientific review of all available information, the regulator states that the available evidence does not indicate that the COVID-19 vaccine from AstraZeneca was the cause of the blood clots in the veins. This conclusion was reached after a detailed study of (clotting) case reports, as well as information on hospitalizations and medical practice records,” the regulator said in a statement.
The MHRA still insists the vaccine is safe and believes people should agree to be vaccinated when it is offered. “Our recommendation remains that the benefits of COVID-19 vaccination still outweigh any possible risks, people should be vaccinated when offered,” the regulator said.
Earlier, on March 15, U.K. Prime Minister Boris Johnson said the AstraZeneca coronavirus vaccine is safe, and British authorities confidently continue mass vaccination of the population.
Last week, the MHRA said it found no evidence that AstraZeneca’s coronavirus vaccine causes blood clots. The U.K. government, as well as the manufacturer, AstraZeneca, said the vaccine is safe.
The AstraZeneca vaccine used in Britain is not produced in the same facilities as those used in the EU and other parts of the world.